+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

XELJANZ Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

XELJANZ Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
STELARA Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

STELARA Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
SIMPONI Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

SIMPONI Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
ENTYVIO Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

ENTYVIO Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
Psoriatic Arthritis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Psoriatic Arthritis - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 141 Pages
  • Global
From
Cytokine Release Syndrome (CRS) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Cytokine Release Syndrome (CRS) - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 141 Pages
  • Global
From
LUPKYNIS Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

LUPKYNIS Market Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
From
From
PALFORZIA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

PALFORZIA Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
Global Endometriosis Pain - Pipeline Insight, 2022 - Product Thumbnail Image

Global Endometriosis Pain - Pipeline Insight, 2022

  • Drug Pipelines
  • August 2022
  • 60 Pages
  • Global
From
Antibody-Mediated Rejection - Epidemiology Forecast - 2032 - Product Thumbnail Image

Antibody-Mediated Rejection - Epidemiology Forecast - 2032

  • Report
  • August 2022
  • 78 Pages
  • Global
From
From
Aicardi Goutieres Syndrome - Epidemiology Forecast - 2032 - Product Thumbnail Image

Aicardi Goutieres Syndrome - Epidemiology Forecast - 2032

  • Report
  • August 2022
  • 62 Pages
  • Global
From
BENLYSTA Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

BENLYSTA Market Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
Ankylosing Spondylitis (Bekhterev's Disease) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Ankylosing Spondylitis (Bekhterev's Disease) - Epidemiology Forecast - 2032

  • Drug Pipelines
  • February 2022
  • 105 Pages
  • Global
From
Axial Spondyloarthritis (axSpA) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Axial Spondyloarthritis (axSpA) - Epidemiology Forecast - 2032

  • Drug Pipelines
  • February 2022
  • 114 Pages
  • Global
From
From
Crohn's Disease (CD) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Crohn's Disease (CD) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more